BI 2536, a Plk1 enzyme inhibitor, was suggested to induce mitotic arrest and a subsequent surge in apoptosis (43) and suppress the expression of epithelial-mesenchymal transition markers and 3D spheroid formation in breast cancer (44). Here, PLK1 is linked to breast cancer.